Carl Zeiss Meditec Q2 revenues increased by 13.2 percent year-on-year to €504 million but the company’s operating profit (EBIT) for the period went down to €84 million, versus €103 million for Q2 2021. For the first half of the fiscal year, EBIT went down by 18.8 percent to €144 million. ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.